Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

This paper reports the results of an important multinational trial which evaluated the use of 2 different regimens of posaconazole in the treatment of OPC or EC, which had been refractory to either fluconazole or itraconazole.

Posaconazole for Azole-Refractory Candidiasis in Patients with HIV Infection